Sreoshi Chatterjee 452 posts 0 comments

TFS International and Arclon Biotech decided to continue their partnership with TFS advancing their Alzheimer's disease vaccine ABvac40 into phase II. AD is a progressive disease…
Read More...

For routine prophylaxis of bleeding episodes in people with hemophilia A with factor VIII inhibitors, Chugai Pharmaceuticals sought positive response from EU Committee for Medicinal…
Read More...

Intelligent Retinal Imaging Systems (IRIS), asserted the appointment of Chris Belmont as interim CEO effective immediately.  IRIS also named Steve Martin as Chief Commercial Officer and…
Read More...

Sterling Pharma Solutions witnessed growth in the Japanese market owing to its technical capabilities and innovation strategy. Sterling's technology and innovation strategy, which has…
Read More...

Avista Pharma Solutions completed acquisition of  Solid Form Solutions located in Edinburgh, Scotland. Solid Form Solutions provider of solid state chemistry and crystallization…
Read More...

Alligator Biosciences affirmed the appointment of Theradex Oncology as CRO for the planned phase I study of ATOR-1015 for the treatment of metastatic cancer anticipated to begin in the…
Read More...

Leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform, REGENXBIO, forays…
Read More...

Veracyte asserted that till date its has performed 100,000 Afirma genomic tests to quell unwanted surgeries in patients being assessed for potential thyroid cancer. The announcement…
Read More...

CASI  Pharmaceuticals, committed to ushering in quality pharmaceutical products to the Chinese and U.S markets proclaimed that it has obtained a portfolio of 25 U.S FDA- approved…
Read More...

Behavioral health and addiction recovery center in Houston, Texas, Sacred Oak Medical Center rescinds agreement with RedShift Healthcare Management, LLC with effect from immediate…
Read More...